Company Profiles

driven by the PitchBook Platform

Archer Pharmaceuticals

Description

Developer of drugs for Alzheimer’s disease. The company is engage din the research and development of Nilvadipine as a therapeutic for Alzheimer’s Disease.

2008

Founded

PRIVATE

Status

11-50

Employees

Grant

Latest Deal Type

$150k

Latest Deal Amount

$2.7M

Total Amount Raised

Description

Developer of drugs for Alzheimer’s disease. The company is engage din the research and development of Nilvadipine as a therapeutic for Alzheimer’s Disease.

Website:

www.archerpharma.com

Ownership Status

Privately Held (backing)

Financing Status

Angel-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

2040 Whitfield Avenue Sarasota, FL 34243United States +1 (941) 755-6644
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Archer Pharmaceuticals's full profile, request a free trial.

    Archer Pharmaceuticals Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Archer Pharmaceuticals Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Archer Pharmaceuticals Executive Team (3)

    NameTitleBoard
    Seat
    Contact
    Info
    Michael Mullan MDChief Executive Officer, Chief Scientific Officer & Board Member
    Jerry SmithChief Financial Officer
    Fiona Crawford Ph.DChief Technology Officer & Associate Chief Scientific Officer
    Michael Mullan MD Chief Executive Officer, Chief Scientific Officer & Board Member
    Jerry Smith Chief Financial Officer
    Fiona Crawford Ph.D Chief Technology Officer & Associate Chief Scientific Officer

    Archer Pharmaceuticals Board Members (1)

    NameRepresentingRoleSinceContact
    Info
    Michael Mullan MDArcher PharmaceuticalsChief Executive Officer, Chief Scientific Officer & Board Member000 0000
    Michael Mullan MD Chief Executive Officer, Chief Scientific Officer & Board Member Archer Pharmaceuticals
    Request full access to PitchBook